Medicaments classification confirmed for povidone iodine surgical preparations based on therapeutic and prophylactic use over cleansing function.

Povidone Iodine Cleansing Solution USP and Wokadine Surgical Scrub were held to be medicaments under Chapter 3003 of the Central Excise Tariff Act, 1985 rather than organic surface active or cleansing preparations under Chapter 3402.90. Their essential character was found to be medicinal because they contained Povidone Iodine as the active ingredient, were labelled for surgical scrub and preoperative degerming use, and were shown by pharmacopoeias and medical literature to function as topical antiseptics and disinfectants with prophylactic effect. The presence of detergents, preservatives, and a smaller medicinal component did not change classification, as the decisive factors were composition, label, common parlance, functional utility, and predominant therapeutic and prophylactic use.

---

---

Issues: Whether Povidone Iodine Cleansing Solution USP and Wokadine Surgical Scrub are classifiable as medicaments under Chapter 30 of the Central Excise Tariff Act, 1985 or as organic surface active preparations and cleansing preparations under Chapter 3402.90.

Analysis: The products contained Povidone Iodine as the active medicinal ingredient along with surface active agents and a preservative. Their labels described them as surgical scrub and showed preoperative use for degerming surgeons' hands and preparing patients before surgery. The material on record, including pharmacopoeias and medical literature, showed that Povidone Iodine is used as a topical antiseptic and disinfectant with prophylactic effect. The presence of detergents and the small proportion of the medicinal ingredient did not alter the essential character of the goods, because classification depends on composition, label, character, common parlance, functional utility and predominant use. Since the goods were purchased and used primarily for therapeutic and prophylactic purposes, Chapter 30, being the specific entry, prevailed over Chapter 3402.90, which was residuary in nature.

Conclusion: The products are classifiable as medicaments under Chapter 3003 of the Central Excise Tariff Act, 1985 and not under Chapter 3402.90.

---